Cargando…

Serum levels of matrix metalloproteinases -1,-2,-3 and -9 in thoracic aortic diseases and acute myocardial ischemia

BACKGROUND: Matrix metalloproteinases (MMPs) constitute a family of zinc-dependent proteases (endopeptidases) whose catalytic action is the degradation of the extracellular matrix components. In addition, they play the major role in the degradation of collagen and in the process of tissue remodeling...

Descripción completa

Detalles Bibliográficos
Autores principales: Karapanagiotidis, Georgios T, Antonitsis, Polychronis, Charokopos, Nicholas, Foroulis, Christophoros N, Anastasiadis, Kyriakos, Rouska, Efthymia, Argiriadou, Helena, Rammos, Kyriakos, Papakonstantinou, Christos
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2774681/
https://www.ncbi.nlm.nih.gov/pubmed/19886986
http://dx.doi.org/10.1186/1749-8090-4-59
_version_ 1782173966397341696
author Karapanagiotidis, Georgios T
Antonitsis, Polychronis
Charokopos, Nicholas
Foroulis, Christophoros N
Anastasiadis, Kyriakos
Rouska, Efthymia
Argiriadou, Helena
Rammos, Kyriakos
Papakonstantinou, Christos
author_facet Karapanagiotidis, Georgios T
Antonitsis, Polychronis
Charokopos, Nicholas
Foroulis, Christophoros N
Anastasiadis, Kyriakos
Rouska, Efthymia
Argiriadou, Helena
Rammos, Kyriakos
Papakonstantinou, Christos
author_sort Karapanagiotidis, Georgios T
collection PubMed
description BACKGROUND: Matrix metalloproteinases (MMPs) constitute a family of zinc-dependent proteases (endopeptidases) whose catalytic action is the degradation of the extracellular matrix components. In addition, they play the major role in the degradation of collagen and in the process of tissue remodeling. The present clinical study investigated blood serum levels of metalloproteinases- 1, -2, -3 and -9 in patients with acute and chronic aortic dissection, thoracic aortic aneurysm and acute myocardial ischemia compared to healthy individuals. METHODS: The blood serum levels of MMP-1, -2, -3 and -9 were calculated in 31 patients with acute aortic dissection, 18 patients with chronic aortic dissection, 18 patients with aortic aneurysm and in 13 patients with acute myocardial ischemia, as well as in 15 healthy individuals who served as the control group. Serum MMP levels were measured by using an ELISA technique. RESULTS: There were significantly higher levels of MMP-3 in patients with acute myocardial ischemia as compared to acute aortic dissection (17.33 ± 2.03 ng/ml versus 12.92 ± 1.01 ng/ml, p < 0.05). Significantly lower levels of MMP-1 were found in healthy controls compared to all groups of patients (1.1 ± 0.38 ng/ml versus 2.97 ± 0.68 in acute aortic dissection, 3.09 ± 0.98 in chronic dissection, 3.16 ± 0.51 in thoracic aortic aneurysm and 4.58 ± 1.04 in acute myocardial ischemia, p < 0.05). Higher levels of MMP-1 and MMP-3 were detected on males. There was a positive correlation with increasing age (r = 0.38, p < 0.05). In patients operated for acute type A aortic dissection, the levels of MMP-1, MMP-3 and MMP-9 increased immediately after surgery, while the levels of MMP-2 decrease. At 24 hours postoperatively, levels of MMP -1, -2 and -9 are almost equal to the preoperative ones. CONCLUSION: Measurement of serum MMP levels in thoracic aortic disease and acute myocardial ischemia is a simple and relatively rapid laboratory test that could be used as a biochemical indicator of aortic disease or acute myocardial ischemia, when evaluated in combination with imaging techniques.
format Text
id pubmed-2774681
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27746812009-11-10 Serum levels of matrix metalloproteinases -1,-2,-3 and -9 in thoracic aortic diseases and acute myocardial ischemia Karapanagiotidis, Georgios T Antonitsis, Polychronis Charokopos, Nicholas Foroulis, Christophoros N Anastasiadis, Kyriakos Rouska, Efthymia Argiriadou, Helena Rammos, Kyriakos Papakonstantinou, Christos J Cardiothorac Surg Research Article BACKGROUND: Matrix metalloproteinases (MMPs) constitute a family of zinc-dependent proteases (endopeptidases) whose catalytic action is the degradation of the extracellular matrix components. In addition, they play the major role in the degradation of collagen and in the process of tissue remodeling. The present clinical study investigated blood serum levels of metalloproteinases- 1, -2, -3 and -9 in patients with acute and chronic aortic dissection, thoracic aortic aneurysm and acute myocardial ischemia compared to healthy individuals. METHODS: The blood serum levels of MMP-1, -2, -3 and -9 were calculated in 31 patients with acute aortic dissection, 18 patients with chronic aortic dissection, 18 patients with aortic aneurysm and in 13 patients with acute myocardial ischemia, as well as in 15 healthy individuals who served as the control group. Serum MMP levels were measured by using an ELISA technique. RESULTS: There were significantly higher levels of MMP-3 in patients with acute myocardial ischemia as compared to acute aortic dissection (17.33 ± 2.03 ng/ml versus 12.92 ± 1.01 ng/ml, p < 0.05). Significantly lower levels of MMP-1 were found in healthy controls compared to all groups of patients (1.1 ± 0.38 ng/ml versus 2.97 ± 0.68 in acute aortic dissection, 3.09 ± 0.98 in chronic dissection, 3.16 ± 0.51 in thoracic aortic aneurysm and 4.58 ± 1.04 in acute myocardial ischemia, p < 0.05). Higher levels of MMP-1 and MMP-3 were detected on males. There was a positive correlation with increasing age (r = 0.38, p < 0.05). In patients operated for acute type A aortic dissection, the levels of MMP-1, MMP-3 and MMP-9 increased immediately after surgery, while the levels of MMP-2 decrease. At 24 hours postoperatively, levels of MMP -1, -2 and -9 are almost equal to the preoperative ones. CONCLUSION: Measurement of serum MMP levels in thoracic aortic disease and acute myocardial ischemia is a simple and relatively rapid laboratory test that could be used as a biochemical indicator of aortic disease or acute myocardial ischemia, when evaluated in combination with imaging techniques. BioMed Central 2009-11-03 /pmc/articles/PMC2774681/ /pubmed/19886986 http://dx.doi.org/10.1186/1749-8090-4-59 Text en Copyright © 2009 Karapanagiotidis et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Karapanagiotidis, Georgios T
Antonitsis, Polychronis
Charokopos, Nicholas
Foroulis, Christophoros N
Anastasiadis, Kyriakos
Rouska, Efthymia
Argiriadou, Helena
Rammos, Kyriakos
Papakonstantinou, Christos
Serum levels of matrix metalloproteinases -1,-2,-3 and -9 in thoracic aortic diseases and acute myocardial ischemia
title Serum levels of matrix metalloproteinases -1,-2,-3 and -9 in thoracic aortic diseases and acute myocardial ischemia
title_full Serum levels of matrix metalloproteinases -1,-2,-3 and -9 in thoracic aortic diseases and acute myocardial ischemia
title_fullStr Serum levels of matrix metalloproteinases -1,-2,-3 and -9 in thoracic aortic diseases and acute myocardial ischemia
title_full_unstemmed Serum levels of matrix metalloproteinases -1,-2,-3 and -9 in thoracic aortic diseases and acute myocardial ischemia
title_short Serum levels of matrix metalloproteinases -1,-2,-3 and -9 in thoracic aortic diseases and acute myocardial ischemia
title_sort serum levels of matrix metalloproteinases -1,-2,-3 and -9 in thoracic aortic diseases and acute myocardial ischemia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2774681/
https://www.ncbi.nlm.nih.gov/pubmed/19886986
http://dx.doi.org/10.1186/1749-8090-4-59
work_keys_str_mv AT karapanagiotidisgeorgiost serumlevelsofmatrixmetalloproteinases123and9inthoracicaorticdiseasesandacutemyocardialischemia
AT antonitsispolychronis serumlevelsofmatrixmetalloproteinases123and9inthoracicaorticdiseasesandacutemyocardialischemia
AT charokoposnicholas serumlevelsofmatrixmetalloproteinases123and9inthoracicaorticdiseasesandacutemyocardialischemia
AT foroulischristophorosn serumlevelsofmatrixmetalloproteinases123and9inthoracicaorticdiseasesandacutemyocardialischemia
AT anastasiadiskyriakos serumlevelsofmatrixmetalloproteinases123and9inthoracicaorticdiseasesandacutemyocardialischemia
AT rouskaefthymia serumlevelsofmatrixmetalloproteinases123and9inthoracicaorticdiseasesandacutemyocardialischemia
AT argiriadouhelena serumlevelsofmatrixmetalloproteinases123and9inthoracicaorticdiseasesandacutemyocardialischemia
AT rammoskyriakos serumlevelsofmatrixmetalloproteinases123and9inthoracicaorticdiseasesandacutemyocardialischemia
AT papakonstantinouchristos serumlevelsofmatrixmetalloproteinases123and9inthoracicaorticdiseasesandacutemyocardialischemia